Page last updated: 2024-08-23

cefoperazone and flomoxef

cefoperazone has been researched along with flomoxef in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's4 (57.14)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jolivette, LJ; Ward, KW1
Arakawa, Y; Ishikawa, K; Nagano, N; Nagano, Y; Wachino, J1
Araki, N; Korkusuz, F; Ono, K; Shinto, Y; Uchida, A1
Kobayashi, J; Kouda, M; Kumagai, I; Matsuzaki, H; Sugai, R1
Nakagawa, Y; Toyoguchi, T1
Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E1
Akiyama, K; Endo, H; Hiramatsu, N; Koyama, T; Nishinari, C; Suzuki, Y1

Other Studies

7 other study(ies) available for cefoperazone and flomoxef

ArticleYear
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
    Journal of pharmaceutical sciences, 2005, Volume: 94, Issue:7

    Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution

2005
Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1

    Topics: Amino Acid Sequence; beta-Lactamases; Blotting, Southern; Ceftazidime; Cephalosporins; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Homology, Amino Acid; Shigella sonnei

2009
Calcium hydroxyapatite ceramic used as a delivery system for antibiotics.
    The Journal of bone and joint surgery. British volume, 1992, Volume: 74, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Biological Assay; Cefoperazone; Cephalosporins; Ceramics; Drug Carriers; Durapatite; Gentamicins; Hydroxyapatites; In Vitro Techniques; Microbiological Techniques; Osteomyelitis; Rats; Rats, Inbred Strains

1992
[Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. II. In vitro combined effects of sulbactam/cefoperazone with imipenem/cilastatin, cefuzonam, flomoxef, amikacin or tobramycin].
    The Japanese journal of antibiotics, 1991, Volume: 44, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Cefoperazone; Ceftizoxime; Cephalosporins; Cilastatin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Sulbactam; Tobramycin

1991
[Nephrotoxicity and drug interaction of vancomycin (2)].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1996, Volume: 107, Issue:5

    Topics: Animals; Blood Urea Nitrogen; Cefoperazone; Ceftazidime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Creatinine; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Imipenem; Kidney; Male; Organ Size; Rabbits; Vancomycin

1996
Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 beta-lactam antibiotics.
    Oral microbiology and immunology, 2002, Volume: 17, Issue:5

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroidaceae Infections; beta-Lactams; Cefepime; Cefmetazole; Cefoperazone; Cefpirome; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Fusobacterium; Fusobacterium Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Mouth Diseases; Penicillin G; Penicillins; Peptostreptococcus; Porphyromonas gingivalis; Prevotella; Streptococcal Infections; Streptococcus; Sulbactam

2002
[Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2001--II. Gram-negative bacteria].
    The Japanese journal of antibiotics, 2003, Volume: 56, Issue:4

    Topics: Cefepime; Cefoperazone; Cefozopran; Cefpirome; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Gram-Negative Bacteria; Humans; Moraxella

2003